Biggest News Aggregation in the World
📰 Pharma Partnering News

Page 2 - Pharma Partnering News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pharma Partnering. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech

Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech ACCESSWIRE 25 May 2021, 22:05 GMT+10 Pieris will receive $20 million as an upfront payment and is eligible to receive more than $1.4 billion in additional potential milestone payments plus royalties for commercialized programs Collaboration includes initial programs in respiratory disease and ophthalmology, with opportunity to nominate additional programs BOSTON, MA / ACCESSWIRE / May 25, 2 021 / Pieris...
United States Stephens Yoder Maria Kelman James Sabry Drug Administration Pieris Pharmaceuticals

Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics

Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics Ribometrix, Inc., today announced a strategic collaboration with Genentech, a member of the Roche Group, to discover and develop novel RNA-targeted small molecule therapeutics against several targets. Ribometrix is focused on leveraging its RNA structural expertise...
North Carolina United States Michael Solomon Tom Donovan James Sabry Ribometrix Inc

Genentech Launches $1B+ RNA Collaboration with Ribometrix

Genentech Launches $1B+ RNA Collaboration with Ribometrix Ribometrix has shown that several RNAs associated with disease contain structural pockets—clefts and crevices (highlighted)—that are amenable to targeting with small molecules. Genentech, a member of the Roche Group, will apply Ribometrix’s discovery platform to discover, develop and commercialize small molecule drug candidates against RNA targets, through a collaboration that could generate more than $1 billion for the Durham, NC...
United States Al Iskandariyah Kevin Weeks Michael Solomon Katie Warner James Sabry

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science